PL2277524T3 - Leczenie IBS z zastosowaniem zarówno bakterii probiotycznych, jak i sfermentowanych zbóż jako efektorów leczenia - Google Patents
Leczenie IBS z zastosowaniem zarówno bakterii probiotycznych, jak i sfermentowanych zbóż jako efektorów leczeniaInfo
- Publication number
- PL2277524T3 PL2277524T3 PL10182284T PL10182284T PL2277524T3 PL 2277524 T3 PL2277524 T3 PL 2277524T3 PL 10182284 T PL10182284 T PL 10182284T PL 10182284 T PL10182284 T PL 10182284T PL 2277524 T3 PL2277524 T3 PL 2277524T3
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- ibs
- effectors
- probiotic bacteria
- fermented cereal
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title 1
- 235000013339 cereals Nutrition 0.000 title 1
- 239000012636 effector Substances 0.000 title 1
- 239000006041 probiotic Substances 0.000 title 1
- 230000000529 probiotic effect Effects 0.000 title 1
- 235000018291 probiotics Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/152—Cereal germ products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
- A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72127605P | 2005-09-28 | 2005-09-28 | |
EP05388079A EP1769801A1 (en) | 2005-09-28 | 2005-09-28 | Use of a fermented cereal composition for the treatment of IBD and IBS |
US74471706P | 2006-04-12 | 2006-04-12 | |
DKPA200600529 | 2006-04-12 | ||
EP06776003.3A EP1931363B1 (en) | 2005-09-28 | 2006-09-27 | Treatment of ibd using both probiotic bacteria and fermented cereal as treatment effectors |
EP10182284.9A EP2277524B1 (en) | 2005-09-28 | 2006-09-27 | Treatment of IBS using both probiotic bacteria and fermented cereal as treatment effectors |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2277524T3 true PL2277524T3 (pl) | 2016-06-30 |
Family
ID=43385150
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10182284T PL2277524T3 (pl) | 2005-09-28 | 2006-09-27 | Leczenie IBS z zastosowaniem zarówno bakterii probiotycznych, jak i sfermentowanych zbóż jako efektorów leczenia |
PL06776003T PL1931363T3 (pl) | 2005-09-28 | 2006-09-27 | Leczenie IBD z zastosowaniem zarówno bakterii probiotycznych, jak i sfermentowanych zbóż jako efektorów leczenia |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06776003T PL1931363T3 (pl) | 2005-09-28 | 2006-09-27 | Leczenie IBD z zastosowaniem zarówno bakterii probiotycznych, jak i sfermentowanych zbóż jako efektorów leczenia |
Country Status (10)
Country | Link |
---|---|
US (6) | US20080311097A1 (pl) |
EP (3) | EP2277524B1 (pl) |
JP (4) | JP5363811B2 (pl) |
AU (1) | AU2006296837B2 (pl) |
CA (1) | CA2622951A1 (pl) |
DK (3) | DK3067057T3 (pl) |
ES (2) | ES2561584T3 (pl) |
PL (2) | PL2277524T3 (pl) |
SI (2) | SI2277524T1 (pl) |
WO (1) | WO2007036230A1 (pl) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2277524B1 (en) * | 2005-09-28 | 2015-11-11 | Nordisk Rebalance A/S | Treatment of IBS using both probiotic bacteria and fermented cereal as treatment effectors |
ES2395838T3 (es) * | 2007-12-21 | 2013-02-15 | Compagnie Gervais Danone | Método para disminuir el contorno abdominal administrando una bacteria del tipo Bifidobacterium |
FI20085101L (fi) * | 2008-02-05 | 2009-08-06 | Valio Oy | Menetelmä ärtyneen suolen oireyhtymän IBS diagnosoimiseksi |
FI121912B (fi) | 2008-02-05 | 2011-06-15 | Valio Oy | Probioottien uusi käyttö |
US8825503B2 (en) | 2008-05-15 | 2014-09-02 | Youdocs, Llc | Methods and systems for improving human health using targeted probiotics |
NL1036661C2 (en) * | 2009-03-04 | 2010-09-07 | Serrix B V | Anti-fungal compounds & compositions. |
WO2011047153A1 (en) * | 2009-10-15 | 2011-04-21 | President And Fellows Of Harvard College | Methods for modulating autoimmunity |
JP5932662B2 (ja) * | 2009-12-22 | 2016-06-08 | プロビ アクティエボラーグ | 穀物ベースフラクション及びプロバイオティックを含む非発酵組成物、並びにそれらの使用 |
US9138441B2 (en) * | 2009-12-31 | 2015-09-22 | Ira Milton Trachtman | Compositions and method for treatment and prophylaxis of inflammatory bowel disease |
WO2011148219A1 (en) | 2010-05-28 | 2011-12-01 | Compagnie Gervais Danone | Probiotic strains for use in improving the enteric nervous system |
WO2011148220A1 (en) | 2010-05-28 | 2011-12-01 | Compagnie Gervais Danone | Probiotic strains for use in improving transepithelial resistance |
TWI392498B (zh) * | 2010-07-19 | 2013-04-11 | Synbio Tech Inc | 戊糖乳桿菌lps16及其在抑制幽門螺旋桿菌之用途 |
RU2567009C2 (ru) | 2010-12-17 | 2015-10-27 | Компани Жервэ Данон | ШТАММ Lactococcus lactis ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ РАССТРОЙСТВА ПИЩЕВАРЕНИЯ И ЕГО ПРИМЕНЕНИЕ |
MX354047B (es) * | 2011-06-08 | 2018-02-09 | Novozymes As | Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori. |
US9579353B2 (en) * | 2011-06-10 | 2017-02-28 | Prothera, Inc. | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes |
JP5928774B2 (ja) * | 2011-11-01 | 2016-06-01 | 株式会社大阪ソーダ | β−1,3−グルカンを含む過敏性腸症候群の下痢抑制剤、腹痛改善剤、及び大腸における痛覚過敏改善剤 |
PL2780023T3 (pl) * | 2011-11-16 | 2018-06-29 | Multigerm Uk Entpr Ltd | Leczenie IBS za pomocą probiotyków |
JP5468183B2 (ja) * | 2011-12-28 | 2014-04-09 | 株式会社山田養蜂場本社 | IgA産生促進作用を有する新規乳酸菌及びその用途 |
WO2013101019A1 (en) * | 2011-12-29 | 2013-07-04 | Hill's Pet Nutrition, Inc. | Compositions and methods for modifying gastrointestinal flora |
DE102012002592A1 (de) | 2012-02-13 | 2013-08-14 | Dr. Kurt Wolff Gmbh & Co. Kg | Verwendung eines Mittels zur Stimulation der Gen-Expression antimikrobieller Peptide (AMP) |
US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
US11179427B2 (en) | 2013-01-21 | 2021-11-23 | Eth Zurich | Baby food composition comprising viable propionic acid-producing bacteria |
DE102013100891A1 (de) * | 2013-01-29 | 2014-07-31 | Erdinger Weissbräu Franz Brombach e.K. | Verfahren zur Herstellung eines Sauergutes, einer Maische oder Würze, eines Getränks, eines Konzentrats sowie die damit hergestellten Erzeugnisse und Verwendung von Milchsäurebakterien, eines Sauerguts, einer Maische, einer Würze oder eines Konzentrats |
DE102013008335A1 (de) * | 2013-01-29 | 2014-07-31 | Erdinger Weissbräu Franz Brombach e.K. | Verfahren zur Herstellung eines Nahrungsmittels sowie das damit hergestellte Nahrungsmittel und Verwendung von Milchsäurebakterien, eines Sauerguts, einer Maische, einer Würze, eines Getränks oder eines Konzentrats |
KR102222273B1 (ko) | 2013-02-04 | 2021-03-08 | 세레스 테라퓨틱스, 인코포레이티드 | 조성물 및 방법 |
EP2951283A4 (en) | 2013-02-04 | 2017-01-25 | Seres Therapeutics, Inc. | Compositions and methods |
AU2014232370B2 (en) * | 2013-03-15 | 2018-11-01 | Seres Therapeutics, Inc. | Network-based microbial compositions and methods |
CN104208294B (zh) * | 2013-09-29 | 2018-01-16 | 河南后羿实业集团有限公司 | 一种用于治疗仔猪黄白痢的中药组合物及其制备方法 |
KR102379658B1 (ko) | 2013-11-25 | 2022-03-28 | 세레스 테라퓨틱스, 인코포레이티드 | 상승적 박테리아 조성물 및 그것의 생산 방법 및 용도 |
US9956282B2 (en) | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
CN104435354A (zh) * | 2014-11-21 | 2015-03-25 | 王正琦 | 治疗儿童消化不良的口服液 |
CN104524006A (zh) * | 2014-12-26 | 2015-04-22 | 邓小健 | 健胃消食片及其生产方法 |
GB201501938D0 (en) * | 2015-02-05 | 2015-03-25 | Multigerm Uk Entpr Ltd | Probiotic preparation |
CN104623145A (zh) * | 2015-02-12 | 2015-05-20 | 苏州市天灵中药饮片有限公司 | 一种用于治疗细菌性痢疾的中药提取物及其制备方法 |
EP3294308A4 (en) | 2015-05-14 | 2019-03-06 | University of Puerto Rico | PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN |
CN108135948B (zh) * | 2015-08-25 | 2022-04-12 | 免疫生物技术医疗瑞典公司 | 用于治疗和预防肠感染和炎症的组合物和方法 |
JP6954563B2 (ja) * | 2015-09-10 | 2021-10-27 | ウニベルシテ カソリーク デ ルーベン | 代謝障害を処置するための低温殺菌アッカーマンシアの使用 |
JP6759337B2 (ja) * | 2015-10-26 | 2020-09-23 | シージェー チェイルジェダン コーポレーション | 酵素生産能が優秀である伝統発酵食品由来の新たな菌株及びこれを用いた穀物発酵酵素食品の製造方法 |
US11564667B2 (en) | 2015-12-28 | 2023-01-31 | New York University | Device and method of restoring microbiota of newborns |
LT3411052T (lt) | 2016-02-04 | 2021-01-11 | Universiteit Gent | Mikrobinių bendrijų naudojimas žmogaus ir gyvūno sveikatos pagerinimui |
JP6329206B2 (ja) * | 2016-06-30 | 2018-05-23 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 消化管フローラを改良する組成物および方法 |
US11633486B2 (en) | 2017-04-17 | 2023-04-25 | The University Of Chicago | Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease |
WO2018204757A1 (en) * | 2017-05-04 | 2018-11-08 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
US11174293B2 (en) | 2017-06-02 | 2021-11-16 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
GB201709763D0 (en) | 2017-06-19 | 2017-08-02 | Probi Ab | Biological materials and methods |
EP3668527A1 (en) | 2017-08-14 | 2020-06-24 | Seres Therapeutics, Inc. | Compositions and methods for treating cholestatic disease |
US10485253B2 (en) | 2017-08-21 | 2019-11-26 | Mustapha Benmoussa | Method of microalgal biomass processing for high-value chemicals production, the resulting composition of butyrogenic algal slowly fermenting dietary fiber, and a way to improve colon health using a slowly fermenting butyrogenic algal dietary fiber |
EP3453395B1 (en) * | 2017-09-08 | 2023-10-18 | Deutsches Rheuma-Forschungszentrum Berlin | Anaeroplasmatales for use in the treatment or prevention of an inflammatory disorder of the digestive system |
JP7215026B2 (ja) * | 2018-09-13 | 2023-01-31 | ライオン株式会社 | 口腔用組成物 |
CN110624060A (zh) * | 2019-07-25 | 2019-12-31 | 秦剑 | 一种治疗幼儿腹泻的中药制剂及其制备方法 |
CN110452860A (zh) * | 2019-09-24 | 2019-11-15 | 厦门大学 | 一种唾液链球菌及其在治疗炎症性肠病药物中的应用 |
TWI777475B (zh) * | 2021-03-30 | 2022-09-11 | 豐華生物科技股份有限公司 | 使用乳酸菌菌株組合來治療第1型糖尿病 |
WO2023135274A1 (en) | 2022-01-14 | 2023-07-20 | Nordic Rebalance A/S | Compositions for treatment of a fatty liver or fibrotic liver disease |
WO2024017920A1 (en) | 2022-07-18 | 2024-01-25 | Nordic Rebalance A/S | Composition comprising fermented cereal gruel |
CN115969957B (zh) * | 2022-12-21 | 2023-07-11 | 浙江佰穗莱生命健康科技有限公司 | 一种炎性肠病复合益生菌制剂及其制备方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4839281A (en) | 1985-04-17 | 1989-06-13 | New England Medical Center Hospitals, Inc. | Lactobacillus strains and methods of selection |
AU624067B2 (en) | 1986-12-12 | 1992-06-04 | Biorem C.C. | Preparation suitable for use in the treatment of enteric disorders |
DK686187D0 (da) | 1987-12-23 | 1987-12-23 | Hansens Chr Bio Syst | Veterinaert praeparat |
SE463796B (sv) | 1988-03-09 | 1991-01-28 | Carl Erik Albertsson | Foerfarande foer framstaellning av en naeringskomposition och daervid framstaelld naeringskomposition |
EP0414941B1 (de) | 1989-08-30 | 1993-07-28 | Siemens Aktiengesellschaft | Stellantrieb |
WO1991005850A1 (en) | 1989-10-10 | 1991-05-02 | Tartusky Gosudarstvenny Universitet | Bacterium strain lactobacillus plantarum 38 for production of a bacterial biological preparation |
WO1991005851A1 (en) | 1989-10-10 | 1991-05-02 | Tartusky Gosudarstvenny Universitet | Bacterium strain lactobacillus casei subsp. casei 37 for production of a bacterial biological preparation |
FI88856C (fi) | 1990-05-18 | 1997-07-01 | Alko Yhtioet Oy | Foerfarande foer framstaellning av ett fermenterat, huvudsakligen pao havrekli baserat, levande mikroorganismer innehaollande livsmedel |
SE469875C (sv) * | 1991-07-25 | 1997-04-14 | Probi Ab | Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen |
SE9501056D0 (sv) * | 1995-03-23 | 1995-03-23 | Probi Ab | Epithelial adherent lactobacilli |
SE9501719D0 (sv) | 1995-05-09 | 1995-05-09 | Probi Ab | Pharmaceutical composition |
WO1998043498A1 (fr) | 1997-04-01 | 1998-10-08 | Nichimo Co., Ltd. | Produit comprenant un ingredient favorable a la sante et son procede de production |
SE511025C2 (sv) | 1997-10-03 | 1999-07-26 | Probi Ab | Foderprodukt för häst omfattande Lactobacillus plantarum JI:1 samt Lactobacillus plantarum JI:1 och användning därav |
SE523771C2 (sv) * | 1999-05-21 | 2004-05-18 | Probi Ab | Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller |
MXPA02009342A (es) | 2000-03-24 | 2003-09-22 | Nestle Sa | Uso de bacterias de acido lactico para el tratamiento de la peritonitis. |
SE0003045D0 (sv) | 2000-08-29 | 2000-08-29 | Probi Ab | New method |
DE10042825A1 (de) | 2000-08-30 | 2002-03-28 | New Food Ag | Wurst- und Pökelware |
SE0004124D0 (sv) * | 2000-11-10 | 2000-11-10 | Probi Ab | New use |
GB0027761D0 (en) | 2000-11-14 | 2000-12-27 | Nestle Sa | Nutritional composition for an immune condition |
EP1243273A1 (en) | 2001-03-22 | 2002-09-25 | Societe Des Produits Nestle S.A. | Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters |
US20040166198A1 (en) | 2001-04-25 | 2004-08-26 | Kiers Jeroen Lucas | Process for the manufacture of a fermented health-promoting product |
DE10219684A1 (de) * | 2001-05-04 | 2002-11-14 | Unternehmensberatung Reichenau | Ernährungsprodukt, Pflegeprodukt und Herstellungsverfahren |
DE10258129A1 (de) | 2002-12-02 | 2004-06-17 | Andrea Reichenauer-Feil | Lebensmittelzubereitung |
SE526711C2 (sv) | 2003-01-31 | 2005-10-25 | Probi Ab | Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav |
SE527555C2 (sv) | 2003-04-04 | 2006-04-11 | Probi Ab | Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar |
EP2277524B1 (en) * | 2005-09-28 | 2015-11-11 | Nordisk Rebalance A/S | Treatment of IBS using both probiotic bacteria and fermented cereal as treatment effectors |
-
2006
- 2006-09-27 EP EP10182284.9A patent/EP2277524B1/en active Active
- 2006-09-27 PL PL10182284T patent/PL2277524T3/pl unknown
- 2006-09-27 SI SI200632022T patent/SI2277524T1/sl unknown
- 2006-09-27 ES ES06776003.3T patent/ES2561584T3/es active Active
- 2006-09-27 US US12/066,246 patent/US20080311097A1/en not_active Abandoned
- 2006-09-27 DK DK15194713.2T patent/DK3067057T3/da active
- 2006-09-27 DK DK10182284.9T patent/DK2277524T3/en active
- 2006-09-27 EP EP15194713.2A patent/EP3067057B1/en active Active
- 2006-09-27 JP JP2008532598A patent/JP5363811B2/ja not_active Expired - Fee Related
- 2006-09-27 DK DK06776003.3T patent/DK1931363T3/en active
- 2006-09-27 SI SI200632021T patent/SI1931363T1/sl unknown
- 2006-09-27 AU AU2006296837A patent/AU2006296837B2/en not_active Ceased
- 2006-09-27 CA CA002622951A patent/CA2622951A1/en not_active Abandoned
- 2006-09-27 EP EP06776003.3A patent/EP1931363B1/en active Active
- 2006-09-27 ES ES10182284.9T patent/ES2561629T3/es active Active
- 2006-09-27 WO PCT/DK2006/000526 patent/WO2007036230A1/en active Application Filing
- 2006-09-27 PL PL06776003T patent/PL1931363T3/pl unknown
-
2012
- 2012-07-03 US US13/540,827 patent/US8846029B2/en active Active
-
2013
- 2013-03-14 US US13/826,076 patent/US8900570B2/en active Active
- 2013-03-14 US US13/826,208 patent/US9205114B2/en active Active
- 2013-04-10 JP JP2013082426A patent/JP5706461B2/ja not_active Expired - Fee Related
- 2013-04-10 JP JP2013082427A patent/JP5802235B2/ja not_active Expired - Fee Related
-
2015
- 2015-06-04 JP JP2015113693A patent/JP6150353B2/ja active Active
- 2015-08-25 US US14/834,639 patent/US20150359836A1/en not_active Abandoned
-
2017
- 2017-02-15 US US15/433,982 patent/US10286026B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI2277524T1 (sl) | Zdravljenje sindroma razdražljivega črevesja z uporabo probiotičnih bakterij in fermentiranih žit kot efektorjev zdravljenja | |
EP1812023B8 (en) | Lactic acid bacteria as probiotic strains and compositions containing same | |
EP1928995A4 (en) | PREPARATIONS BASED ON VIABLE MICRO-ORGANISMS AND METHODS OF MAKING AND USING SAME | |
HK1145406A1 (en) | Novel bacteria and methods of use thereof | |
EP1859022A4 (en) | NEW SAFETY TOLERANT LACTOBACILLUS SAKEI PROBIO-65 WITH THE CAPACITY TO SUPPORT GROWTH-BASED MICRO-ORGANISMS AND ANTI-ALLERGIC EFFECTS | |
PL384263A1 (pl) | Wariant oksydazy moczanowej i jego zastosowanie | |
ZA200710983B (en) | Bacterial cellulose-containing formulations and method of producing effective bacterial cellulose-containing formulations | |
HK1173747A1 (en) | Induction and stabilization of enzymatic activity in microorganisms | |
HK1115730A1 (en) | Selection and use of lactic acid bacteria for reducing inflammation in mammals | |
EP1900285A4 (en) | FERMENTED FOOD CONTAINING BIFIDOBACTERIUM BACTERIUM AND METHOD FOR PRODUCING THE SAME | |
EP1848798A4 (en) | NEW MICROBIAL ENZYMES AND THEIR USE | |
EP2086333A4 (en) | ISOLATED MYELOID-SIMILAR CELL POPULATIONS AND TREATMENT PROCESSES THEREWITH | |
GB0513096D0 (en) | Treatment of microbial infections | |
GB2445651B (en) | Well treatment products and methods of using them | |
EP1915443A4 (en) | IMMOBILIZED ENZYMES AND USE METHOD THEREFOR | |
EP1781826A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING ORTHOPOXVIRUS | |
IL180459A0 (en) | Treatment of bacterial infections | |
GB2442881B (en) | Methods for altering gene expression and methods of treatment utilizing same | |
GB0504657D0 (en) | Compositions and methods of treatment | |
PT1885848E (pt) | Conversão microbiana de ácidos de açúcar e meios úteis nesta | |
GB0518921D0 (en) | Enzymatic composition and method of textile treatment | |
AU2005901416A0 (en) | Antibiotic and probiotic treatment and packaging | |
AU2005904259A0 (en) | Compositions and methods of treatment | |
AU2005903854A0 (en) | Compositions and methods of treatment | |
AU2005901939A0 (en) | Treatment of Foodstuffs |